Accès gratuit
Numéro
Med Sci (Paris)
Volume 20, Numéro 5, Mai 2004
Page(s) 521 - 525
Section M/S revues
DOI https://doi.org/10.1051/medsci/2004205521
Publié en ligne 15 mai 2004
  1. Murry CE, Jennings RB, Reimer KA. « Preconditioning » with ischemia : a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 5 : 1124–36.
  2. Piot CA, Padmanaban DD, Ursell PC, et al. Ischemic preconditioning decreases apoptosis in rat heart in vivo. Circulation 1997; 96 : 1598–604.
  3. Argaud L, Prigent AF, Chalabreysse L, et al. Ceramide in the antiapoptotic effect of ischemic preconditioning. Am J Physiol Heart Circ Physiol 2004; 286 : H246–51.
  4. Ovize M, Kloner RA, Przyklenk K. Preconditioning and contractile function. In : Przyklenk K, Yellon N, eds. Preconditioning : the concept of endogenous protection. Dordrecht : Kluwer Publisher, 1994.
  5. Ovize M, Przyklenk K, Kloner RA. « Preconditioning » does not attenuate myocardial « stunning ». Circulation 1992; 85 : 2247–54.
  6. Ovize M, Aupetit JF, Rioufol G, et al. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in the pig heart. Am J Physiol 1995; 269 : H72–79.
  7. Shiki K, Hearse DJ. « Preconditioning » of ischemic myocardium :reperfusion-induced arrhythmias. Am J Physiol 1987; 253 : H1470–76.
  8. Ovize M, Przyklenk K, Kloner RA. Stretch preconditions the canine myocardium. Am J Physiol 1994; 266 : H137–46.
  9. Schultz JEL, Rose E, Yao Z, Gross GJ. Evidence for involvment of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995; 268 : H2157–61.
  10. Liu GS, Thornton J, Van Winkle DM, et al. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84 : 350–6.
  11. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72 : 1293–9.
  12. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266 : H1145–52.
  13. Yellon DM, Downey JM. Preconditioning the myocardium : from cellular physiology to clinical cardiology. Physiol rev 2003; 83 : 1113–51.
  14. Garlid KD, Paucek P, Yarov-Yarovoy V. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 1997; 81 : 1072–82.
  15. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70 : 223–33.
  16. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 1991; 352 : 244–7.
  17. O’Rourke B. Mitochondrial K+ATP channels in preconditioning. Circ Res 2000; 87 : 845–55.
  18. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in necrosis and apoptosis. Annu Rev Physiol 1998; 60 : 619–42.
  19. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochem Biophys Acta 1995; 1241 : 139–76.
  20. Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 1993; 27 : 1790–4.
  21. Griffiths EJ, Halestrap AP. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 1993; 25 : 1461–9.
  22. Argaud L, Gateau-Roesch O, Chalabreysse L, et al. Preconditioning delays Ca2+-induced mitochondrial permeability transition. Cardiovasc Res 2004; 61 : 115–22.
  23. Javadov SA, Clarke S, Das M, et al. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 2003; 549 : 513–24.
  24. Piriou V, Chiari P, Gateau-Roesch O, et al. Desflurane-induced preconditioning delays mitochondrial permeability transition pore opening. Anesthesiology 2004; 100 : 581–8.
  25. Wang L, Cherednichenko G, Hernandez L, et al. Preconditioning limits mitochondrial Ca2+ during ischemia in rat hearts : role of K+ATP channels. Am J Physiol 2001; 280 : H2321–8.
  26. Leesar MA, Stoddard MF, Ahmed M, et al. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997; 95 : 2500–7.
  27. Tomai F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994; 90 : 700–5.
  28. IONA Study group. Effect of nicorandil on coronary events in patients with stable angina : the impact of nicorandil in angina (IONA) randomised trial. Lancet 2002; 359 : 1269–75.
  29. Zhao ZQ, Corvera JS, Hlakos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion : comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285 : H579–88.
  30. Derek J, Hausenloy H, Derek M. New directions for protecting the heart against ischaemia-reperfusion injury : targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 2004; 61 : 448–60.
  31. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischemia but open upon reperfusion. Biochem J 1995; 307 : 93–8.
  32. Argaud L, Gateau-Roesch O, Loufouat J, Ovize M. Cyclosporin delays calcium-induced permeability transition when administered at reperfusion. Eur Heart J 2003; 2530 (abstract).

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.